Anticorps Monoclonal anti-TNFRSF21/DR6

TNFRSF21/DR6 Monoclonal Antibody for WB, IF/ICC, Indirect ELISA

Hôte / Isotype

Mouse / IgG1

Réactivité testée

Humain

Applications

WB, IF/ICC, Indirect ELISA

Conjugaison

Non conjugué

CloneNo.

3C2D10

N° de cat : 66754-1-PBS

Synonymes

DR6, TNFRSF21, 3C2D10, CD358, Death receptor 6



Informations sur le produit

66754-1-PBS cible TNFRSF21/DR6 dans les applications de WB, IF/ICC, Indirect ELISA et montre une réactivité avec des échantillons Humain

Réactivité Humain
Hôte / Isotype Mouse / IgG1
Clonalité Monoclonal
Type Anticorps
Immunogène TNFRSF21/DR6 Protéine recombinante Ag14327
Nom complet tumor necrosis factor receptor superfamily, member 21
Masse moléculaire calculée 655 aa, 72 kDa
Poids moléculaire observé 69 kDa
Numéro d’acquisition GenBankBC021572
Symbole du gène DR6
Identification du gène (NCBI) 27242
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par protéine G
Tampon de stockage PBS only
Conditions de stockageStore at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

TNFRSF21 (also known as DR6 or CD358) is an orphan receptor of the tumor necrosis factor (TNF) receptor superfamily. It controls cell death and differentiation in a cell-autonomous manner in different cell types including neurons, oligodendrocytes, endothelial cells, and immune cells (PMID: 29459438). DR6 has been shown to activate NF-κB and JNK, and induce cell apoptosis (PMID: 9714541). DR6 interacts with TRADD, which is known to mediate signal transduction of TNF receptors. It has been reported that APP binds DR6 to trigger axon pruning and neuron death via distinct caspases, indicating that DR6 might be involved in Alzheimer's disease (PMID: 19225519).

{{ptg:RelatedPrimaryAntibodies}}